These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10837102)

  • 1. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine.
    Trzepacz PT
    Semin Clin Neuropsychiatry; 2000 Apr; 5(2):132-48. PubMed ID: 10837102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the neuropathogenesis of delirium.
    Trzepacz PT
    Dement Geriatr Cogn Disord; 1999; 10(5):330-4. PubMed ID: 10473933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Delirium: etiology and pathophysiology].
    Veiga Fernández F; Cruz Jentoft AJ
    Rev Esp Geriatr Gerontol; 2008; 43 Suppl 3():4-12. PubMed ID: 19422109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: a potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release.
    Berlanga ML; Simpson TK; Alcantara AA
    J Comp Neurol; 2005 Nov; 492(1):34-49. PubMed ID: 16175554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathogenesis of delirium: review of current etiologic theories and common pathways.
    Maldonado JR
    Am J Geriatr Psychiatry; 2013 Dec; 21(12):1190-222. PubMed ID: 24206937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Delirium is a very common and life-threatening condition].
    Singler K; Hafner M; Sieber C
    Ther Umsch; 2010 Feb; 67(2):63-7. PubMed ID: 20131213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotogenic drugs and delirium pathogenesis: the central role of the thalamus.
    Gaudreau JD; Gagnon P
    Med Hypotheses; 2005; 64(3):471-5. PubMed ID: 15617851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology of delirium].
    Bogović TZ; Tonković D; Sekulić A; Bandić-Pavlović D; Baronica R; Bogović M; Sakan S; Grcić IF; Tomasević B
    Acta Med Croatica; 2012 Mar; 66(1):61-6. PubMed ID: 23088089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiological aspects of social anxiety disorder.
    Furmark T
    Isr J Psychiatry Relat Sci; 2009; 46(1):5-12. PubMed ID: 19728568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action.
    Hummel M; Unterwald EM
    J Cell Physiol; 2002 Apr; 191(1):17-27. PubMed ID: 11920678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT receptor regulation of neurotransmitter release.
    Fink KB; Göthert M
    Pharmacol Rev; 2007 Dec; 59(4):360-417. PubMed ID: 18160701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate receptors in nucleus accumbens mediate regionally selective increases in cortical acetylcholine release.
    Zmarowski A; Sarter M; Bruno JP
    Synapse; 2007 Mar; 61(3):115-23. PubMed ID: 17146770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
    Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging in delirium and related conditions.
    Lerner DM; Rosenstein DL
    Semin Clin Neuropsychiatry; 2000 Apr; 5(2):98-112. PubMed ID: 10837099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motoric subtypes of delirium.
    Meagher DJ; Trzepacz PT
    Semin Clin Neuropsychiatry; 2000 Apr; 5(2):75-85. PubMed ID: 10837096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Under the curve: critical issues for elucidating D1 receptor function in working memory.
    Williams GV; Castner SA
    Neuroscience; 2006 Apr; 139(1):263-76. PubMed ID: 16310964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine enhances spatiotemporal spread of activity in rat prefrontal cortex.
    Bandyopadhyay S; Gonzalez-Islas C; Hablitz JJ
    J Neurophysiol; 2005 Feb; 93(2):864-72. PubMed ID: 15469958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
    Hernández LF; Segovia G; Mora F
    Neurochem Int; 2008 Feb; 52(3):457-69. PubMed ID: 17881090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic acetylcholine neurotransmission enhances the late-phase of long-term potentiation in the hippocampal-prefrontal cortex pathway of rats in vivo: a possible involvement of monoaminergic systems.
    Lopes Aguiar C; Romcy-Pereira RN; Escorsim Szawka R; Galvis-Alonso OY; Anselmo-Franci JA; Pereira Leite J
    Neuroscience; 2008 Jun; 153(4):1309-19. PubMed ID: 18455317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia as a dynamical disease.
    an der Heiden U
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S36-42. PubMed ID: 16508894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.